Dyan Cornacchio

american conference institute conference pharmaceutical anti-corruption fcpa law fda compliance due diligence regulatory biotechnology life sciences intellectual property international trade internal investigation ethics white-collar crime global compliance anti-money laundering corporate compliance hatch-waxman women leaders biosimilar ipr litigation pharmaceutical patents ptab pto corporate audit internal audit legal affairs general counsel regulatory compliance in-house counsel women lawyers cybersecurity ftc medical devices legal pharmaceutical litigation healthcare fraud information technology/information systems medical device industry r&d biologics life sciences law product liability litigation bpcia biosimilars antitrust risk adjustment managed care medicaid false claims medicare risk counsel healthcare litigation risk corridor litigation generic patents district court judges brand name paragraph iv litigation mma rule hhs uspto paragraph iv consumer health care nutritionals dietary supplements nutraceuticals otc foreign corrupt practices act risk assessment corporate governance anticorruption fcc universal service fund network technology broadband network neutrality cuba cable industries telecom internet engineering spectrum satellite incentive auction wireless wireline télécommunications tyson foods c. bouaphakeo gomez v. campbell-ewald company pbgc ebsa robin v. spokeo erisa bellwether removal esop spokeo tibble defined benefit dol fiduciary regulations ppaca erisa fiduciary class actions claims against service providers defined contribution church plans mdl average manufacturer's price cms amp final rule pharma women attorneys women in finance and compliance women in banking law women in consumer finance law diversity in law leaning in women in financial services law work life balance legal diversity wassenaar intrusion software global encryption cloud network surveillance cosmetics ip social media marketing first to file whistleblower records medicare/medicaid fraud procurement fraud false claim damages off label marketing healthcare false claims anti-kickbacks healthcare compliance fca government contract fraud mortgage false claims financial services false claims sec whistleblower program false claims act qui tam product management & marketing networking engineering business development radio access strategy network technology ran capacity & design network strategy network planning network design special projects network architecture in-building/das systems/solutions telecommunications international products liability litigation drug and medical device litigation personal jurisdiction plaintiffs' advertising products liability cafa off-label promotion torts